Department of Invasive Cardiology, Central Clinical Hospital of Internal Affairs and Administration Ministry, Warsaw, Poland.
Kardiol Pol. 2010 Apr;68(4):381-90.
Significant left main coronary artery stenosis (LMS) conveys adverse prognosis and until recently its treatment has been restricted to surgical intervention. We evaluated the long term outcome of patients with LMS treated using different approaches i.e. medical treatment, surgical (CABG, coronary artery bypass graft) and percutaneous (PCI, percutaneous coronary intervention).
We analysed 450 patients with significant LMS (%DS > 50%). Group 1 (G1) included 105 patients who did not qualify for invasive treatment. Group 2 (G2) included 282 patients who underwent CABG. Group 3 (G3) comprised 67 patients who received stent into LMS. We analysed the incidence of invasive treatment complications in G2 and G3 and the overall incidence of adverse cardiac events that comprised death, repeated myocardial infarction, and the necessity of repeated revascularisation during hospital stay and long term follow-up.
During the 5-year follow-up, the highest mortality was noted in the G1 in comparison to G2 and G3 (31.3% vs 24.5% vs 26.8% respectively). There was no difference in mortality between G2 and G3. The incidence of myocardial infarction was the lowest in G3 (22.2%) followed by G1 (40.8%) and G2 (45.1%). No difference was detected in the occurrence of repeated PCI in LMS (G2 - 19.85%, G3 - 13.4%) and CABG (G1 - 12.2%, G2 - 10.2%, G3 - 9.0%). The incidence of target vessel revascularisation was the highest in G1, followed by G2 and G3 (69.49% vs 53.19% vs 31.35% respectively).
Our study showed that CABG and PCI provide similar long-term outcome in patients with LMS.
严重左主干冠状动脉狭窄(LMS)提示不良预后,直到最近,其治疗一直局限于手术干预。我们评估了采用不同方法治疗的 LMS 患者的长期预后,包括药物治疗、手术(冠状动脉旁路移植术,CABG)和经皮介入(经皮冠状动脉介入治疗,PCI)。
我们分析了 450 例严重 LMS(狭窄程度%DS > 50%)患者。第 1 组(G1)包括 105 例不符合侵入性治疗条件的患者。第 2 组(G2)包括 282 例行 CABG 的患者。第 3 组(G3)包括 67 例接受 LMS 支架置入的患者。我们分析了 G2 和 G3 中侵入性治疗并发症的发生率,以及包括死亡、再次心肌梗死和住院期间及长期随访期间需要再次血运重建的不良心脏事件的总发生率。
在 5 年的随访中,G1 组的死亡率最高,与 G2 和 G3 组相比(分别为 31.3%、24.5%和 26.8%)。G2 和 G3 组之间的死亡率无差异。G3 组心肌梗死发生率最低(22.2%),其次是 G1 组(40.8%)和 G2 组(45.1%)。LMS 重复 PCI 的发生率在 G2 组(19.85%)和 G3 组(13.4%)和 CABG 组(G1 组 12.2%、G2 组 10.2%、G3 组 9.0%)之间无差异。G1 组靶血管血运重建发生率最高,其次是 G2 组和 G3 组(分别为 69.49%、53.19%和 31.35%)。
我们的研究表明,CABG 和 PCI 为 LMS 患者提供了相似的长期预后。